Illumina Inc. announced the newest addition to its next-generation sequencing (NGS) portfolio with the launch of the MiniSeq Sequencing System. Illumina also introduced Infinium XT, and previewed Project Firefly, which will lead to the commercialization of a new semiconductor-based sequencing system. The new MiniSeq System makes Illumina's trusted sequencing technology accessible to all laboratories interested in performing targeted sequencing.

With push-button operation, the flexible benchtop sequencer enables a broad range of DNA and RNA sequencing applications, from examining single genes to entire pathways, in a single run. Priced at $49,500 USD, and cost-efficient to run, the MiniSeq System allows virtually any laboratory to adopt NGS, regardless of sample volume.